OTCMKTS:CRRVF CVR Medical (CRRVF) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisChart About CVR Medical Stock (OTCMKTS:CRRVF) Get CVR Medical alerts:Sign Up Key Stats Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage VolumeN/AMarket Capitalization$32 thousandP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview CVR Medical Corp (OTCMKTS:CRRVF) is a U.S.-based medical technology company specializing in the development and commercialization of proprietary gas-based insufflation systems for gastrointestinal procedures. The company’s platform technologies are designed to improve patient comfort and procedural efficiency during endoscopic interventions, with a primary focus on colonoscopy. CVR Medical’s products leverage hydrogen-based delivery to provide a low-residue, clean gas that can potentially reduce post-procedure discomfort and preparation time for patients. The company’s lead offering, the Clearway™ Hydrogen Insufflation System, has received 510(k) clearance from the U.S. Food and Drug Administration for use in colonoscopic procedures. CVR Medical manufactures its devices in accordance with current Good Manufacturing Practices (cGMP) and markets them directly to hospitals, endoscopy centers and ambulatory surgical facilities across the United States. In addition to in-house sales, the company pursues strategic partnerships and licensing agreements to integrate its insufflation technology into third-party endoscopy platforms. Founded in 2013 and headquartered in Tulsa, Oklahoma, CVR Medical remains focused on expanding clinical adoption of its gas-based systems and advancing its research pipeline. The company collaborates with key opinion leaders in gastroenterology to gather real-world data and explore additional applications of its technology. CVR Medical is led by a management team with expertise in medical device development, regulatory affairs and commercialization, aiming to address unmet needs in gastrointestinal diagnostics and therapeutics.AI Generated. May Contain Errors. Read More Receive CRRVF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for CVR Medical and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. CRRVF Stock News HeadlinesCVR Medical Corp. (CRRVF)August 18, 2024 | nz.finance.yahoo.comCVR Energy (NYSE:CVI) Stock Quotes, Forecast and News SummaryJuly 26, 2024 | benzinga.comElon Musk’s Hushed FCC Filing. Sept 25th.Elon Musk quietly filed a document with the federal government tied to artificial intelligence, one of the largest markets in the world. James Altucher, who previously flagged Nvidia in 2008 and Bitcoin in 2013, says the filing could rival Tesla, SpaceX and xAI combined. Few investors know this filing exists, but that is expected to change quickly.September 20 at 1:00 AM | Paradigm Press (Ad)CVR Partners: Lower Distributions, But Undervalued Compared To Its Peers (Rating Downgrade)August 29, 2023 | msn.comCVR Medical Corp (CVMh)July 21, 2023 | investing.comCVR Medical Corp. Announces Amended Restructuring Agreement with CVR Global, Inc.December 20, 2022 | finance.yahoo.comCVR Medical Corp. Announces Completion of 2022 3rd Quarter Financial StatementDecember 1, 2022 | finance.yahoo.comTikToker shares life-saving tip for getting out of a zip tieSeptember 8, 2022 | yahoo.comSee More Headlines CRRVF Stock Analysis - Frequently Asked Questions How do I buy shares of CVR Medical? Shares of CRRVF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Today9/20/2026Fiscal Year End12/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorHealthcare Industry MEDICAL INFO SYS Sub-IndustryN/A Current SymbolOTCMKTS:CRRVF CIKN/A Webcvrmed.com Phone(734) 718-5115FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares107,233,000Free FloatN/AMarket Cap$32 thousand OptionableNot Optionable Beta32.20 7 Stocks That Will Be Magnificent in 2026Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.Get This Free Report This page (OTCMKTS:CRRVF) was last updated on 9/20/2026 by MarketBeat.com Staff. From Our Partners$40,000,000,000,000The national debt just hit 40 trillion dollars, and the U.S. now spends more on interest payments than on its ...American Alternative | SponsoredA “bloodbath” Is ComingReports suggest some Silicon Valley billionaires are stockpiling gold, guns, and gas masks - or leaving the co...TradeSmith | SponsoredBefore Anthropic becomes impossible to ignore...Riot Platforms just struck a 20-year, 191-megawatt data-center agreement tied to Anthropic, reportedly worth 9...The Oxford Club | SponsoredMan who Predicted Trump 2016 Win: “Prepare for Mid-Term Meltdown”In 2016, major election models gave Hillary Clinton a 99% chance of winning - but former CIA and Pentagon advi...Paradigm Press | SponsoredWhy This Small AI Company Holds 150 PatentsJeff Brown, the tech investor who identified Nvidia in 2016 before its 37,000% run, has flagged a new AI compa...Brownstone Research | SponsoredNo Wallstreet. No Advisor. No Problem.Savings accounts pay just 0.58 percent interest. Andy Howard, co-founder of Meridian Capital, says liquidity p...Awesomely | SponsoredGold majors have a big problemNewmont spent 15 billion dollars acquiring Newcrest in 2023, the largest deal in gold mining history. Yet prod...Golden Portfolio | SponsoredHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CVR Medical Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share CVR Medical With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.